Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot pharmacokinetic and biomarker study of induction chemotherapy toxicity in Ewing sarcoma
2013-000052-17Phase 4Unknown
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Aug 2013
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cyclophosphamide, etoposide, doxorubicin, vincristine and ifosfamide in Ewing sarcoma, sponsored by Newcastle Hospitals NHS Foundation Trust. Status: unknown.
02
Drugs
cyclophosphamideetoposidedoxorubicinvincristineifosfamide
03
Conditions
Ewing sarcoma
Beyond the preview
Go deeper on 2013-000052-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000052-17.